Talaris Therapeutics
Talaris Therapeutics is a therapeutic based company.
Launch date
Employees
Market cap
€115m
Enterprise valuation
(€22m) (Public information from Oct 2023)
Share price
$2.72 TALS
Louisville Kentucky (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
EBITDA | (18.0m) | (22.2m) | (46.9m) | (74.3m) |
Profit | (18.2m) | (22.7m) | (47.8m) | (73.9m) |
R&D budget | 13.4m | 15.3m | 34.2m | 57.0m |
Date | Investors | Amount | Round |
---|---|---|---|
$100m | Series A | ||
* | $100m | Series A | |
$115m | Series B | ||
N/A | N/A | IPO | |
* | N/A | Acquisition | |
Total Funding | €286m |
Related Content
Recent News about Talaris Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.